New Test For Bladder Cancer Will Significantly Improve Quality Of Patient Care
5/29/2013
A simple urine test, developed at the University of Surrey may greatly improve patient quality of life and has the potential to save the NHS in excess of £100 million every year. The test, developed by Dr Richard Morgan and Prof Hardev Pandha looks for traces of the EN -2 protein in the urine, a protein which has been found to exist in bladder and prostate cancer patients...
Researchers at the University of Pittsburgh Graduate School of Public Health have concluded a 12-year, multi-part study into a perceived increase in brain cancer at the Pratt & Whitney jet engine manufacturing plant in North Haven, Conn., and have found no statistically significant elevations in the overall cancer rates among the workforce...
Invivis Pharmaceuticals, Inc., a clinical stage biopharmaceutical private company focused on the development of oncology therapeutics, have announced new, positive data supporting the development of its biomarkers to be presented at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting, May 31-June 4, 2013 in Chicago, Illinois...
Genetic Marker Identified For Sporadic Breast Cancer
5/29/2013
Medical researchers at the University of Alberta have pinpointed a genetic marker for sporadic breast cancer - one of a handful identified to date in Caucasians. Researchers have identified many genetic markers for familial breast cancers, but not for sporadic breast cancer which accounts for 80 per cent of all cases...
Research Identifies A Way To Make Cancer Cells More Responsive To Chemotherapy
5/29/2013
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University explains why some cancer cells don't respond to chemotherapy, and identifies a mechanism to rectify that...
Among men with prostate cancer, African Americans experience longer treatment delays after being diagnosed than Caucasians. That is the finding of an analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society...
Faster Spinal Anesthesia For Cancer Patients At End Of Life
5/29/2013
For patients with uncontrolled pain from terminal cancer, a new approach to calculating initial dosage may allow a quicker start of spinal analgesia - and less time in the hospital, according to a study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS)...
First Drug Targets Identified In Childhood Genetic Tumor Disorder
5/28/2013
Two mutations central to the development of infantile myofibromatosis (IM) - a disorder characterized by multiple tumors involving the skin, bone, and soft tissue - may provide new therapeutic targets, according to researchers from the Icahn School of Medicine at Mount Sinai...
Combating Metastatic Cancer Through Immune System Modulation
5/28/2013
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ignore cancer cells. Regulatory T cells are immune cells that function to suppress the immune system response...
Multicolor Fluorescence Labeling Method Offers Hope For Cancer Diagnosis
5/28/2013
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers...